Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Exchange Rate Effect (2023 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Exchange Rate Effect for 3 consecutive years, with $84000.0 as the latest value for Q3 2025.

  • Quarterly Exchange Rate Effect rose 300.0% to $84000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$46000.0 through Sep 2025, down 224.32% year-over-year, with the annual reading at -$149000.0 for FY2024, 720.83% down from the prior year.
  • Exchange Rate Effect for Q3 2025 was $84000.0 at Xtant Medical Holdings, up from -$19000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $84000.0 in Q3 2025, with the low at -$109000.0 in Q4 2024.
  • Average Exchange Rate Effect over 3 years is -$1125.0, with a median of -$7000.0 recorded in 2024.
  • The sharpest move saw Exchange Rate Effect crashed 241.56% in 2024, then skyrocketed 300.0% in 2025.
  • Over 3 years, Exchange Rate Effect stood at $77000.0 in 2023, then plummeted by 241.56% to -$109000.0 in 2024, then skyrocketed by 177.06% to $84000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $84000.0, -$19000.0, and -$2000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.